Zilovertamab vedotin

Zilovertamab vedotin (VLS-101, MK-2140) is an antibody-drug conjugate (ADC) composed of a humanised monoclonal antibody targeting ROR1 and the anti-mitotic cytotoxic agent monomethyl auristatin E (MMAE). It has potential for the treatment of lymphoid malignancies.
Supplier Selleck Chemicals
Product # D4013
Sku # D4013-1mg
Pricing 1mg, $970.00
Feedback